1. Home
  2. MRSN vs SIDU Comparison

MRSN vs SIDU Comparison

Compare MRSN & SIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • SIDU
  • Stock Information
  • Founded
  • MRSN 2001
  • SIDU 2012
  • Country
  • MRSN United States
  • SIDU United States
  • Employees
  • MRSN N/A
  • SIDU N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • SIDU Telecommunications Equipment
  • Sector
  • MRSN Health Care
  • SIDU Telecommunications
  • Exchange
  • MRSN Nasdaq
  • SIDU Nasdaq
  • Market Cap
  • MRSN 34.0M
  • SIDU 30.0M
  • IPO Year
  • MRSN 2017
  • SIDU 2021
  • Fundamental
  • Price
  • MRSN $6.75
  • SIDU $1.15
  • Analyst Decision
  • MRSN Strong Buy
  • SIDU
  • Analyst Count
  • MRSN 5
  • SIDU 0
  • Target Price
  • MRSN $5.75
  • SIDU N/A
  • AVG Volume (30 Days)
  • MRSN 130.5K
  • SIDU 1.6M
  • Earning Date
  • MRSN 08-12-2025
  • SIDU 08-18-2025
  • Dividend Yield
  • MRSN N/A
  • SIDU N/A
  • EPS Growth
  • MRSN N/A
  • SIDU N/A
  • EPS
  • MRSN N/A
  • SIDU N/A
  • Revenue
  • MRSN $34,006,000.00
  • SIDU $3,860,985.00
  • Revenue This Year
  • MRSN N/A
  • SIDU $144.49
  • Revenue Next Year
  • MRSN $1.03
  • SIDU N/A
  • P/E Ratio
  • MRSN N/A
  • SIDU N/A
  • Revenue Growth
  • MRSN N/A
  • SIDU N/A
  • 52 Week Low
  • MRSN $6.47
  • SIDU $1.08
  • 52 Week High
  • MRSN $70.75
  • SIDU $7.65
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 38.74
  • SIDU 31.00
  • Support Level
  • MRSN $6.55
  • SIDU $1.08
  • Resistance Level
  • MRSN $10.25
  • SIDU $2.19
  • Average True Range (ATR)
  • MRSN 0.70
  • SIDU 0.13
  • MACD
  • MRSN -0.20
  • SIDU -0.10
  • Stochastic Oscillator
  • MRSN 5.41
  • SIDU 6.31

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

Share on Social Networks: